"XORTX Therapeutics Inc. has decided to voluntarily delist its common shares from the TSX Venture Exchange (TSXV). The company aims to reduce costs and regulatory complexity by maintaining a single listing on Nasdaq. Shareholders will retain trading access via Nasdaq."